Abstract:Pei-Ting Lu, 1 Tsung-Hsien Tsai, 1 Chi-Chun Lai, 1, 2 Lan-Hsin Chuang, 1, 2 Shih-Chieh Shao 3, 4 1 Department of Ophthalmology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 2 College of Medicine, Chang Gung University, Taoyuan, Taiwan; 3 Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 4 School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan Correspondence: Lan-Hsin Chuang, Department of Ophthalmology, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Road, Anle Dist, Keelung City, 204, Taiwan, Email Shih-Chieh Shao, Department of Pharmacy, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Road, Anle Dist, Keelung City, 204, Taiwan, Email Background: Healthcare databases play a crucial role in improving our understanding of glaucoma epidemiology, which is the leading cause of irreversible blindness globally. However, the accuracy of diagnostic codes used in these databases to detect glaucoma is still uncertain. Aim: To assess the accuracy of ICD-9-CM and ICD-10-CM codes in identifying patients with glaucoma, including two distinct subtypes, primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). Methods: We analyzed electronic medical records data from a 2% random sample of patients who newly underwent visual field examination in Taiwan's largest multi-institutional healthcare system from 2011 to 2020. The diagnosis of glaucoma was confirmed by two ophthalmologists, based on the glaucoma diagnostic criteria. The positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for ICD-9-CM codes 365.1X and 365.2X, and ICD-10-CM codes H4010X, H4011X, H4012X, H4020X, H4021X, H4022X, H4023X and H4024X for glaucoma were calculated. Results: We randomly selected 821 patients (mean age: 56.9 years old; female: 50.5%) from the original cohort of 41,050 newly receiving visual field examination in the study. Among 464 cases with an ICD-9-CM glaucoma code, the sensitivity, specificity, PPV and NPV for glaucoma were 86.5, 96.5, 91.9, and 90.9%, respectively. Among 357 cases with an ICD-10-CM glaucoma code, the sensitivity, specificity, PPV and NPV for glaucoma were 87.0, 92.8, 92.2 and 87.9%, respectively. The accuracy of diagnostic codes to identify POAG and PACG remained consistent. Conclusion: The diagnostic codes were highly reliable for identifying cases of glaucoma in Taiwan's routine healthcare practice. These results provide confidence when using ICD-9-CM and ICD-10-CM codes to define glaucoma cases in healthcare database research in Taiwan. Keywords: primary open angle glaucoma, primary angle closure glaucoma, ICD-9-CM codes, ICD-10-CM codes, validation, database research, chang gung research database Graphical Glaucoma is the leading cause of irreversible blindness worldwide, 1 and the estimated number of people affected by glaucoma will reach nearly 112 million by the year 2040, having increased from 76 million in 2020. 2–4 Since the epidemiological features of glaucoma are incompletely understood, and treatment strategies are constantly being improved, 5–10 it is important to assess clinical features, risk factors and treatment effectiveness of glaucoma in the population under real-world conditions. Many observational studies using secondary data sources [eg, electronic medical records (EMRs), healthcare data, health insurance claims data or administrative data] have been published to address the clinical questions related to glaucoma, and their findings may improve disease understanding and promote further decisions in clinical practice. For example, based on California Medicare data, Yao et al found that myopia was associated with greater risk of POAG. 11 Shao et al, using Taiwan's EMR data, indicated that use of sodium glucose co-transporter 2 inhibitors was associated with a lower risk of incident glaucoma. 12 Since most secondary database studies identify glaucoma by using the relevant disease diagnostic codes, the impact of misclassification bias may threaten the study validity if the coding accuracy is unclear in these secondary databases. 13 So far, only three validation studies conducted in the USA and UK have assessed the accuracy of glaucoma diagnostic codes in secondary databases. 14–16 However, there is still a need for more extensive evaluations of coding validity for glaucoma. For instance, none of the prior studies examined the accuracy of diagnostic codes specifically related to primary an -Abstract Truncated-

Use of Diagnostic Codes for Primary Open-Angle Glaucoma Polygenic Risk Score Construction in Electronic Health Record-Linked Biobanks

The Clinical Usefulness of a Glaucoma Polygenic Risk Score in 4 Population-Based European Ancestry Cohorts

Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study

Polygenic risk score-based phenome-wide association for glaucoma and its impact on disease susceptibility in two large biobanks

Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden

Interaction of Background Genetic Risk, Psychotropic Medications, and Primary Angle Closure Glaucoma in the UK Biobank

Background polygenic risk modulates the association between glaucoma and cardiopulmonary diseases and measures: an analysis from the UK Biobank

Characteristics of P.gln368ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank

Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration

Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals

Polygenic Risk Scores and Genetically Complex Eye Disease

Development and Evaluation of a Rules-based Algorithm for Primary Open-Angle Glaucoma in the VA Million Veteran Program

Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events

Association Of Gene Polymorphisms With Primary Open Angle Glaucoma: A Systematic Review And Meta-Analysis

Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia

Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening

Population Performance and Individual Agreement of Coronary Artery Disease Polygenic Risk Scores

Validation of Diagnostic Codes to Identify Glaucoma in Taiwan's Claims Data: A Multi-Institutional Study

The Role of Polygenic Risk Scores in Glaucoma Management.

Identification of Optic Nerve-Related Biomarkers in Primary Open-Angle Glaucoma Based on Comprehensive Bioinformatics and Mendelian Randomization